(Total Views: 160)
Posted On: 05/21/2018 4:28:14 PM
Post# of 102837
$MPHMF / $LILY:CSE
Callitas Health Signs Dr. Gregory Smith MD, MPH, as the Company's Chief Medical Cannabis Advisor
CINCINNATI, OH, May 21, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that it has signed industry expert Dr. Gregory Smith MD, MPH, as the Company’s Chief Medical Cannabis Advisor. The addition of Dr. Smith will help give the Company additional product development, clinical study capabilities and visibility in the THC/CBD (cannabinoids) market. For More Information http://www.thestreetnow.com/spotlight/mphmf/ ...
Callitas Health Signs Dr. Gregory Smith MD, MPH, as the Company's Chief Medical Cannabis Advisor
CINCINNATI, OH, May 21, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that it has signed industry expert Dr. Gregory Smith MD, MPH, as the Company’s Chief Medical Cannabis Advisor. The addition of Dr. Smith will help give the Company additional product development, clinical study capabilities and visibility in the THC/CBD (cannabinoids) market. For More Information http://www.thestreetnow.com/spotlight/mphmf/ ...
(0)
(0)
